Masimo (MASI)
(Delayed Data from NSDQ)
$140.65 USD
-0.89 (-0.63%)
Updated Oct 31, 2025 03:59 PM ET
After-Market: $140.60 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MASI 140.65 -0.89(-0.63%)
Will MASI be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for MASI based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for MASI
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
Here's Why You Should Add OPKO Health Stock to Your Portfolio
MASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
Zacks.com featured highlights include The Honest Company, Dutch, AIM ImmunoTech, Masimo and Cognizant Technology Solutions
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
Other News for MASI
Is MASI primed for volatility? Bollinger Band Squeeze shows up after declining 0.63%
Is MASI preparing to trend lower? 50 Day Moving Average Resistance shows up after sliding 0.96%
Is MASI gaining bearish strength? Fell Below 50 Day Moving Average shows up after dropping 2.39%
Non-ADX 1,2,3,4 Bullish appears for MASI after 1.07% move
20 Day Moving Average Support appears for MASI after 0.15% move